Increasing Quality And Reducing Costs With AI-Powered Pharmaceutical Inspection Technologies

The pharmaceutical industry encounters unique manufacturing and production process challenges, especially with rapid digital technology transfer. In parenteral pharmaceutical manufacturing, the visual inspection of primary packaging, such as vials, syringes, and ampoules, is crucial. This process aims to detect product defects, impurities, or contaminants in every product.

Automatic visual inspection (AVI) is widely used in the industry, but it often results in false reject rates (FRR) that can necessitate costly re-inspections. Traditional vision tools for ensuring reliable detection are often time-consuming, expensive, and prone to errors, contributing to increased expenses due to false reject rates. Beyond the financial impact of re-inspections, high false reject rates can also cause delays in product releases and missed opportunities in the market.

AI-supported inspection processes offer a future-proof solution to these challenges. Learn how to get started with AI-supported inspection.